识别一个罕见的呈现:低血压周期性二次使用安非他命使用
Hamza Naveed1, Crystal Ike1, Laith M Haj-Ahmad2
1University of Houston/HCA Houston Healthcare, Houston, Texas, USA.
Nephrology (Carlton, Vic.)
|May 13, 2025
概括
胺诱导的低血压周期性会导致呼吸衰竭. 这一案例凸显了和有滥用药物病史的患者迅速识别和治疗的必要性.
科学领域:
- 神经学 神经学
- 毒理学 毒理学 毒理学
- 紧急医疗 紧急医疗
背景情况:
- 低性周期性 (HPP) 是一种由于低水平而导致暂时肌肉衰弱的疾病.
- 胺使用可以引发HPP,这是一个罕见但严重的并发症.
研究的目的:
- 报告一种独特的甲基胺诱导的低血压周期性病例.
- 在这种情况下,强调可能导致危及生命的呼吸衰竭.
主要方法:
- 案例报告:一名31岁的男性使用甲基胺,出现.
- 实验室分析显示严重的低血和高水平的肌酸酶.
- 积极的替代和呼吸辅助,包括机械通风.
主要成果:
- 患者经历了四相,低血 (1.8 mmol/L) 和急性超气呼吸衰竭,需要输管.
- 在15小时内静脉和胃口补充,使水平正常化.
- 第二天,成功地进行了输出管,并完全恢复了运动力.
结论:
- 胺诱导的HPP可以导致关键的隔膜和呼吸衰竭.
- 医生应该怀疑在患有急性和药物滥用病史的患者中存在安非他命诱导的HPP.
- 迅速补充和呼吸系统监测对于恢复至关重要.
相关概念视频
Myasthenia Gravis: Diagnostic Tests
554
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
554
Antihypertensive Drugs: Potassium-Sparing Diuretics
407
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
407
Drugs Acting on Autonomic Ganglia: Stimulants
1.2K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.2K
Antiepileptic Drugs: Potassium Channel Activators
127
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
127
Depolarizing Blockers: Mechanism of Action
1.1K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
1.1K
Desensitization and Tachyphylaxis
1.4K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.4K


